Vanguard Portfolio Management
NVCR icon

Vanguard Portfolio Management’s NovoCure NVCR Stock Holding History

Vanguard Portfolio Management’s Portfolio NVCR Stock Details NVCR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$95M Buy
6,272,490
+20,789
+0.3% +$315K ﹤0.01% 1520
2026
Q1 		$68.1M Buy
+6,251,701
New +$78.1M ﹤0.01% 1572

Other funds holding NVCR

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
SCM
Soleus Capital Management Greenwich, Connecticut $2.9B AUM 169.69% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return
QCM
Quantinno Capital Management New York $83.3B AUM 37.97% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Vanguard Portfolio Management's NVCR Position: Q2 2026 in Review

Vanguard Portfolio Management increased its NovoCure (NVCR) stake by 0.33% in Q2 2026, buying an estimated $315K and bringing the position to 6,272,490 shares worth $95M. The position accounts for ﹤0.01% of the portfolio, ranked #1520.

Vanguard Portfolio Management first reported a position in NVCR in Q1 2026 and has held it in 2 quarters since. 215 funds tracked by Wall St. Rank hold NVCR as of Q2 2026.

  • Vanguard Portfolio Management held 6,272,490 shares of NovoCure worth $95M as of Q2 2026.
  • Vanguard Portfolio Management bought 20,789 NovoCure shares in Q2 2026, an estimated $315K.
  • NovoCure made up ﹤0.01% of Vanguard Portfolio Management's portfolio in Q2 2026, its #1520 holding.
  • Vanguard Portfolio Management first reported a position in NovoCure in Q1 2026 and has held it in 2 quarters since.
  • 215 funds tracked by Wall St. Rank held NovoCure as of Q2 2026.

Based on Vanguard Portfolio Management's 13F filing for Q2 2026, filed 13 Aug 2026.